Article Details

Single-domain antibodies make a difference

Retrieved on: 2021-02-11 18:56:15

Tags for this article:

Click the tags to see associated articles and topics

Single-domain antibodies make a difference. View article details on hiswai:

Excerpt

Clinical trials using intravenously administered neutralizing monoclonal antibodies that target SARS-CoV-2 spike indicate benefit in outpatients (more ...

Article found on: science.sciencemag.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up